Real-World heart safety check for prostate cancer drug
NCT ID NCT06010914
Summary
This study is collecting safety information on an approved prostate cancer drug combination in real-world medical practice. It will follow about 100 Japanese men with advanced prostate cancer that has spread and is still sensitive to hormone therapy. The main goal is to monitor for heart-related side effects and other problems while patients receive their standard treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many Locations
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.